medline.ch Respirationstrakt Neoplasie

	Evaluating Effective Biomarker Testing for Advanced Non-Small Cell Lung Cancer in US Community Oncology Practices. JCO Oncol Pract Thomas CA, Blau S, Neuhalfen H, Williams C, Peevyhouse A, Gajra A, Dranitsaris G. PMID: 42018972 [PubMed - as supplied by publisher]
	Biomarker Testing Rates and Patterns in Patients With Metastatic Non-Small Cell Lung Cancer: A Prospective, Observational Study in Community Practices. JCO Precis Oncol Evangelist M, Wang B, Butrynski JE, Paschold J, Ward PJ, Waterhouse DM, Jotte RM, Ali K, Richards DA, Konduri K, Melnyk A, Owera RS, Hakimian D, Ghaddar H, Lander EM, Robert NJ, Yori JL, Upadhyay V, Spigel DR, Johnson ML. PMID: 42018966 [PubMed - indexed for MEDLINE]
	Feasibility, outcomes, and cost analysis of robotic head and neck surgery in the Public Health System. Einstein (Sao Paulo) Kulcsar MAV, Vanni CMRS, Matos LL, Brandão LG, Kowalski LP, Cernea CR, Souza DGS. PMID: 42018824 [PubMed - indexed for MEDLINE]
	Clinical and Molecular Characterization of a Rare EGFR cis Compound L833V/H835L Mutation in Non-Small Cell Lung Cancer. Cancer Res Commun Jeon YH, Lim A, Choi MK, Choi HS, Lee Y, Song H, Cho HS, Cho J, Choi YL. PMID: 42018150 [PubMed - indexed for MEDLINE]
	Pre-diagnosis recreational physical activity and lung cancer survival within the California teachers study. Cancer Causes Control Cauble EL, Blanchard M, Reynolds P, Spielfogel ES, Clague DeHart J. PMID: 42018036 [PubMed - indexed for MEDLINE]
	Artificial intelligence construction: a review of the bridge between CT imaging features of lung ground-glass nodules adenocarcinoma and carcinogenic driver genes. J Cancer Res Clin Oncol Xue W, Chen J. PMID: 42017975 [PubMed - indexed for MEDLINE]
	Opportunities and challenges of immunotherapy for patients with resectable and potentially resectable stage III non-small cell lung cancer. Cancer Biol Med Cui Y, Xu J, Wen J, Peng J, Ren J, Liu A, Meng X, Huang Z, Liu A. PMID: 42017760 [PubMed - as supplied by publisher]
	Evaluating zongertinib in the treatment of patients with HER2-mutant non-small cell lung cancer. Future Oncol Kim J, Ahn MJ. PMID: 42017474 [PubMed - as supplied by publisher]
	Patient-Derived Lung Cancer Organoids for Precision Oncology: A Comprehensive Analysis. JTO Clin Res Rep Chen D, Sun Z, Li J, Wang X, Li Y, Mao Y, Chen Y. PMID: 42016718 [PubMed]
	Pretest-posttest trial of a lung cancer screening decision aid for individuals with multimorbidity from a primary care population. PEC Innov Koster KM, Minardi F, Feinberg A, Schonberg M, Schnur JB, Wisnivesky JP, Diefenbach MA, Kale MS. PMID: 42016588 [PubMed]
	The predictive value and clinical application of measuring circulating endothelial progenitor cells in lung adenocarcinoma. J Cardiothorac Surg Zhang L, Liu Z, Zhang Y, Wu Z, Liu Y, Wang Z. PMID: 42015273 [PubMed - as supplied by publisher]
	Unraveling the multidimensional pleural ecosystem of lung cancer-associated malignant pleural effusion. Cancer Cell Int Cui S, Wang G, Sun X, Wang Z, Zhou G, Jiang H. PMID: 42015232 [PubMed - as supplied by publisher]
	The association between the advanced lung cancer inflammation index and carotid plaque in non-dialysis CKD stage 3-5 patients: a cross-sectional study. BMC Cardiovasc Disord Wang L, Wang J, Ji J, Xiang F, Zhang L, Jiang X, Fang Y, Ding X, Jiang W. PMID: 42014974 [PubMed - as supplied by publisher]
	Multiclass lung cancer detection using a hybrid capsule inspired deep neural network. Sci Rep Bhattacharee A, Bhattacharjee A, Swain RP, Sahu RK. PMID: 42014820 [PubMed - as supplied by publisher]
	Cauchy Lotus Optimization-based feature selection and ResNet 101 based XceptionNet architecture for radiation pneumonitis prediction in lung cancer patients. Med Dosim Byeon H, Ezhilan M, Kale-Thombre PP, Lawrence J, Lazha A, Johnson S. PMID: 42014218 [PubMed - as supplied by publisher]
	Single-cell spatial analysis stratifies lung adenocarcinoma with rare actionable mutations and reveals immune-modulatory cellular crosstalk. Cell Rep Med Ma J, Li X, Qian N, Li S, Li L, Zhang X, Su L, Yang Y, Luo H, Yin M, Zhang M. PMID: 42013848 [PubMed - as supplied by publisher]
	Chemoimmunotherapy for localized non-small cell lung cancer: A new standard for all stage III? Cancer Radiother Martin É, Kaderbhai C, Bonnet F, Chevalier C, Rakotosamimanana M, Pouypoudat C, Baude J. PMID: 42013679 [PubMed - as supplied by publisher]
	Long-Term Efficacy and Safety of Taletrectinib in Patients With ROS1+ Non-Small Cell Lung Cancer: Results From the Phase II TRUST-I Study. J Clin Oncol Li W, Zhang Y, Fan H, Yu Q, Ran F, Chen W, Zhou C. PMID: 42013573 [PubMed - as supplied by publisher]
	Immune-related gene expression profiling and alectinib efficacy for patients with ALK-Rearranged non-small cell lung cancer: exploratory analysis of a prospective observational study. Lung Cancer Kurosaki T, Suzuki S, Watanabe Y, Kenmotsu H, Itoh S, Yamaguchi M, Shiono A, Suzuki T, Yokoyama T, Toi Y, Tanaka H, Oki M, Tsuda T, Ichihara E, Azuma K, Tanaka H, Arai R, Uchibori K, Miyauchi E, Katayama R, Hayashi H. PMID: 42013562 [PubMed - as supplied by publisher]
	Trajectory Analysis of Family Resilience and Family Vulnerability in Lung Cancer Surgery Patients: A Longitudinal Qualitative Study. Psychooncology Zhu J, Li XT, Gao SR, Yan H, Ye M. PMID: 42012782 [PubMed - indexed for MEDLINE]

Artikel 1 - 20 / 159015

Seite 1 von 7951



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung